ImportRefusal LogoImportRefusal

Sanofi Aventis France

⚠️ Moderate Risk

FEI: 3008575899 • Paris, Paris • FRANCE

FEI

FEI Number

3008575899

📍

Location

Paris, Paris

🇫🇷

Country

FRANCE
🏢

Address

1 boulevard Romain Rolland, , Paris, Paris, France

Moderate Risk

FDA Import Risk Assessment

42.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

11
Total Refusals
7
Unique Violations
8/26/2019
Latest Refusal
7/29/2009
Earliest Refusal

Score Breakdown

Violation Severity
73.5×40%
Refusal Volume
40.0×30%
Recency
0.0×20%
Frequency
10.9×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

759×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

163×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

821×

RX LEGEND

The article appears to be a prescription drug without a prescription drug legend as required by Section 503(b)(4).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

32601×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 801.15(c)(1)

Refusal History

DateProductViolationsDivision
8/26/2019
62GLM46KETOPROFEN (ANTI-INFLAMMATORY)
118NOT LISTED
16DIRECTIONS
3260NO ENGLISH
3280FRNMFGREG
75UNAPPROVED
Division of Northeast Imports (DNEI)
1/31/2018
62KAY08LOPERAMIDE HYDROCHLORIDE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/21/2016
66VDA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/3/2016
61NCC55SULPIRIDE (ANTI-DEPRESSANT)
16DIRECTIONS
Philadelphia District Office (PHI-DO)
8/24/2016
61MCB35DIVALPROEX SODIUM (ANTI-CONVULSANT)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/25/2016
61PCL17INSULIN (INJ) (ANTI-DIABETIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/25/2016
64OCA05SILTUXIMAB, MONOCLONAL ANTIBODIES
75UNAPPROVED
New Orleans District Office (NOL-DO)
9/21/2012
66VAA99MISCELLANEOUS PATENT MEDICINES, ETC.
16DIRECTIONS
472NO ENGLISH
82RX LEGEND
New York District Office (NYK-DO)
6/19/2012
61NCB99ANTI-DEPRESSANT N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
4/27/2012
56CCA64CEFPODOXIME PROXETIL (CEPHALOSPORINS)
75UNAPPROVED
New Orleans District Office (NOL-DO)
7/29/2009
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Sanofi Aventis France's FDA import refusal history?

Sanofi Aventis France (FEI: 3008575899) has 11 FDA import refusal record(s) in our database, spanning from 7/29/2009 to 8/26/2019.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Sanofi Aventis France's FEI number is 3008575899.

What types of violations has Sanofi Aventis France received?

Sanofi Aventis France has been cited for 7 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Sanofi Aventis France come from?

All FDA import refusal data for Sanofi Aventis France is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.